Ashley Moody (R-FL)

Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2026

S. 3922 · Senate bill Health

A Republican bill with 1 Republican cosponsor · See the cosponsor

Last activity — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, titled the "Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2026," aims to amend the Federal Food, Drug, and Cosmetic Act. It specifically seeks to clarify the Food and Drug Administration's jurisdiction over certain tobacco products. The legislation is designed to protect jobs and small businesses involved in the sale, manufacturing, and distribution of traditional and premium cigars. It creates an exception for specific types of cigars, limiting the Secretary's authority to regulate them.

Yes· 3 of 4

  • Scored +5

    Does this make it easier to run a small business?

    The bill specifically targets the preservation of small businesses involved in the traditional cigar industry by limiting FDA oversight.

  • Scored +5

    Would business owners be better off under this?

    The bill provides significant relief to business owners in the traditional cigar manufacturing industry.

  • Scored +3

    Is this likely to create jobs?

    The bill seeks to protect jobs within the traditional cigar manufacturing and distribution industry.

The opposite

  • Scored -4

    Does this give the federal government more power?

    The bill restricts federal regulatory authority held by the FDA over specific tobacco products.

  • Scored -3

    Does this give people more protection from unfair business practices?

    The bill reduces FDA regulatory oversight, which could potentially impact consumer safety standards for tobacco products.